CALR and ovarian cancer: Data published recently by Lau et al. [114] showed that paclitaxel (but not cisplatin and carboplatin) effectively induced membrane CRT expression on human SK-OV-3 and mouse ID8 ovarian cancer cell lines, in vitro.